SHILPA MEDICARE LTD
SHILPA MEDICARE LTD (India) holds 1 active US FDA Type II Drug Master File and 1 inactive, has DMF or CEP filings on record for 2 active ingredients and is linked to 3 FDA-registered manufacturing sites. 18 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “SHILPA MEDICARE LTD: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/shilpa-medicare-ltd
Overview
SHILPA MEDICARE LTD is an active pharmaceutical ingredient (API) supplier with 1 active FDA Type II Drug Master File, covering SUNITINIB.
Core services & business areas
Active ingredients with DMF or CEP filings
Substances for which SHILPA MEDICARE LTD holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.
API / Drug Master Files
SHILPA MEDICARE LTD holds 1 active (2 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.
- SUNITINIBActive2021-04-21
- ANASTROZOLEInactive2009-09-23
Registered manufacturing sites (3)
Physical sites registered with the US FDA and resolved to SHILPA MEDICARE LTD, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
FDA compliance signals
18 FDA enforcement records linked to this company.
- recall — Class II2026-08-26
Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
- recall — Class II2026-08-26
Discolored solution. The firm has received market complaints reporting green to dark green discoloration in certain vials
- 4832024-10-30
Complete instructions, procedures, specifications et. al.
- 4832024-10-30
Calibration/Inspection/Checking not done
- 4832024-10-30
Signature and checking of records -- 2 persons
- 4832024-10-30
Written record of investigation incomplete
- 4832023-03-10
Following/documenting laboratory controls
- 4832023-03-10
Lab controls established, including changes
- recall — Class II2020-12-16
CGMP Deviations
- recall — Class II2020-12-16
CGMP Deviations
- recall — Class II2020-12-16
CGMP Deviations
- recall — Class II2020-12-16
CGMP Deviations
- recall — Class II2020-12-16
CGMP Deviations
- recall — Class II2020-12-16
CGMP Deviations
- warning_letter2020-10-09
FDA Warning Letter (drug product)
- 4832019-09-06
Written program not followed
- 4832019-09-06
Instruments, apparatus, et. al. not meeting specs
- 4832019-02-13
Lab controls established, including changes
Is this SHILPA MEDICARE LTD?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Related companies
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.